Shopping Cart
- Remove All
Your shopping cart is currently empty
CLX 0921, a PPAR gamma agonist, is used potentially for the treatment of type 2 diabetes.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 2-4 weeks | |
| 50 mg | $1,980 | 2-4 weeks | |
| 100 mg | $2,500 | 2-4 weeks |
| Description | CLX 0921, a PPAR gamma agonist, is used potentially for the treatment of type 2 diabetes. |
| Targets&IC50 | PPARγ:1.54 μM |
| Synonyms | THR-0921, THR0921, THR 0921, CLX-0921, CLX0921 |
| Molecular Weight | 519.57 |
| Formula | C28H25NO7S |
| Cas No. | 249886-47-3 |
| Relative Density. | 1.308 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.